Company-level financial information
CONMED Corp
Selected annual earnings and cash-flow facts from SEC filings. Each row identifies its exact reporting period and original filing.
Annual net income
| Reporting period | Measure | USD millions | Filing |
|---|---|---|---|
| Dec 31, 2025From Jan 1, 2025 | Operating cash flow | 170.7 | SEC filingFeb 17, 2026 |
| Dec 31, 2025From Jan 1, 2025 | Net income | 47.1 | SEC filingFeb 17, 2026 |
| Dec 31, 2025From Jan 1, 2025 | Common-stock cash dividends | 24.7 | SEC filingFeb 17, 2026 |
| Dec 31, 2025From Jan 1, 2025 | Capital expenditures (PP&E) | 19.8 | SEC filingFeb 17, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Operating cash flow | 167.0 | SEC filingFeb 17, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Net income | 132.4 | SEC filingFeb 17, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Common-stock cash dividends | 24.7 | SEC filingFeb 17, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Capital expenditures (PP&E) | 13.1 | SEC filingFeb 17, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Operating cash flow | 125.3 | SEC filingFeb 17, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Net income | 64.5 | SEC filingFeb 17, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Common-stock cash dividends | 24.5 | SEC filingFeb 17, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Capital expenditures (PP&E) | 19.0 | SEC filingFeb 17, 2026 |
| Dec 31, 2022From Jan 1, 2022 | Operating cash flow | 33.4 | SEC filingFeb 18, 2025 |
| Dec 31, 2022From Jan 1, 2022 | Net income | -80.6 | SEC filingFeb 18, 2025 |
| Dec 31, 2022From Jan 1, 2022 | Common-stock cash dividends | 24.0 | SEC filingFeb 18, 2025 |
| Dec 31, 2022From Jan 1, 2022 | Capital expenditures (PP&E) | 21.8 | SEC filingFeb 18, 2025 |
| Dec 31, 2021From Jan 1, 2021 | Operating cash flow | 111.8 | SEC filingFeb 28, 2024 |
| Dec 31, 2021From Jan 1, 2021 | Net income | 62.5 | SEC filingFeb 28, 2024 |
| Dec 31, 2021From Jan 1, 2021 | Common-stock cash dividends | 23.3 | SEC filingFeb 28, 2024 |
| Dec 31, 2021From Jan 1, 2021 | Capital expenditures (PP&E) | 14.9 | SEC filingFeb 28, 2024 |
| Dec 31, 2020From Jan 1, 2020 | Operating cash flow | 64.5 | SEC filingFeb 21, 2023 |
| Dec 31, 2020From Jan 1, 2020 | Net income | 9.5 | SEC filingFeb 21, 2023 |
| Dec 31, 2020From Jan 1, 2020 | Common-stock cash dividends | 22.8 | SEC filingFeb 21, 2023 |
| Dec 31, 2020From Jan 1, 2020 | Capital expenditures (PP&E) | 13.0 | SEC filingFeb 21, 2023 |
| Dec 31, 2019From Jan 1, 2019 | Operating cash flow | 95.1 | SEC filingFeb 22, 2022 |
| Dec 31, 2019From Jan 1, 2019 | Net income | 28.6 | SEC filingFeb 22, 2022 |
| Dec 31, 2019From Jan 1, 2019 | Common-stock cash dividends | 22.6 | SEC filingFeb 22, 2022 |
| Dec 31, 2019From Jan 1, 2019 | Capital expenditures (PP&E) | 20.1 | SEC filingFeb 22, 2022 |